Search for: "PFIZER"
Results 3481 - 3500
of 4,635
Sort by Relevance
|
Sort by Date
21 Oct 2009, 12:43 pm
The value of some firms extends beyond costs and deliverables (See my post of June 20, 2008: achieve value for money; Aug. 28, 2009: Pfizer requests "value reports"; Sept. 12, 2008: value proposition of regional and local law firms; and Oct. 4, 2009: no one ever got fired for hiring [big name] firm.). [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 4:22 am
Pfizer-style) and several directors do not receive a majority of the vote in the election, the board's subsequent rejection of the directors' resignation letters is not, by itself, enough to serve as a credible basis of wrongdoing in a books and records request brought under Section 220 of the Delaware General Corporation Law. [read post]
19 Oct 2009, 4:30 am
Pfizer, Inc., 381 F. [read post]
18 Oct 2009, 5:59 pm
Harris (08-1385) Pfizer Inc. v. [read post]
16 Oct 2009, 6:52 am
Considering what it takes for a drug to actually be pulled from the shelves, it would seem that Merck, Pfizer, Bayer and all the other multi-billion dollar drug conglomerates are free to advertise as much and as recklessly as they please, regardless of the consequences or dangers to consumers. [read post]
16 Oct 2009, 6:52 am
Considering what it takes for a drug to actually be pulled from the shelves, it would seem that Merck, Pfizer, Bayer and all the other multi-billion dollar drug conglomerates are free to advertise as much and as recklessly as they please, regardless of the consequences or dangers to consumers. [read post]
15 Oct 2009, 3:10 am
If the article you are searching does not appear go to the top of the screen and click on Law.Com Newswire and scroll down to the appropriate article:
FTC Clears $68 Billion Pfizer-Wyeth Merger
Calif. [read post]
15 Oct 2009, 2:17 am
Pfizer posted earnings of $48.3 billion in 2008, while Wyeth reaped $23 billion in revenue. [read post]
14 Oct 2009, 1:24 pm
Antitrust experts we talked to back in January were right: Federal regulators Thursday gave the go-ahead to Pfizer's $68 billion purchase of Wyeth. [read post]
14 Oct 2009, 12:31 pm
Pfizer is required to provide Boehringer with key services to help it compete after the consummation of the deal. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
14 Oct 2009, 6:26 am
Pfizer's Acquisition of Wyeth Clears Antitrust HurdlesThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Pfizer, Inc.'s proposed $68 billion acquisition of Wyeth was conditionally approved by the Federal Trade Commission (FTC) today. [read post]
13 Oct 2009, 9:59 pm
As part of the effort to encourage these companies to pool their patents, MSF has launched an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to place specific HIV drug patents... [read post]
9 Oct 2009, 9:11 am
Actavis Elizabeth LLC, Anchen Pharmaceuticals Inc. and Anchen Incorporated (patent infringement) 10/6: Pfizer Inc., Pfizer Pharmaceuticals LLC, Pfizer Ireland Pharmaceuticals, Pfizer Limited and CP Pharmaceuticals International CV v. [read post]
9 Oct 2009, 12:00 am
Earlier this month, drug giant Pfizer agreed to pay a $2.3 billion penalty to settle claims over payment of kickbacks and illegal drug marketing and promotion that violated federal drug laws over an extensive period of time. [read post]
8 Oct 2009, 12:37 pm
Pfizer, Inc. v. [read post]
5 Oct 2009, 10:08 pm
Bloomberg notes:New York-based Pfizer and other pharmaceutical companies overcame attempts to torpedo a deal they made with Finance Committee Chairman Max Baucus and Obama that limits their contribution to the overhaul to $80 billion over 10 years. [read post]
